BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30005953)

  • 1. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
    Navran A; Heemsbergen W; Janssen T; Hamming-Vrieze O; Jonker M; Zuur C; Verheij M; Remeijer P; Sonke JJ; van den Brekel M; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():25-31. PubMed ID: 30005953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction.
    Al-Mamgani A; Kessels R; Janssen T; Navran A; van Beek S; Carbaat C; Schreuder WH; Sonke JJ; Marijnen CAM
    Radiother Oncol; 2022 Mar; 168():16-22. PubMed ID: 35065998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes.
    Al-Mamgani A; Kessels R; Navran A; Hamming-Vrieze O; Zuur CL; Paul de Boer J; Jonker MCJ; Janssen T; Sonke JJ; Marijnen CAM
    Radiother Oncol; 2021 Sep; 162():170-177. PubMed ID: 34311003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.
    Ariyaratne H; Chesham H; Pettingell J; Alonzi R
    Radiother Oncol; 2016 Oct; 121(1):103-108. PubMed ID: 27576431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite minimax robust optimization of VMAT improves target coverage and reduces non-target dose in head and neck cancer patients.
    Wagenaar D; Kierkels RGJ; Free J; Langendijk JA; Both S; Korevaar EW
    Radiother Oncol; 2019 Jul; 136():71-77. PubMed ID: 31015132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of action levels in imaging strategies in head and neck cancer using TomoTherapy. Are our margins adequate in the absence of image guidance?
    Houghton F; Benson RJ; Tudor GS; Fairfoul J; Gemmill J; Dean JC; Routsis DS; Jefferies SJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):720-7. PubMed ID: 19740637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy.
    Adil K; Popovic M; Cury FL; Faria SL; Duclos M; Souhami L
    Pract Radiat Oncol; 2019 Jan; 9(1):24-28. PubMed ID: 30096379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
    Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
    Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.
    Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
    J Radiat Res; 2015 Jan; 56(1):141-50. PubMed ID: 25304328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
    van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
    de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
    Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A comparative analysis of dosimetry for target volume and organs at risk.
    Akiyama H; Pesznyák C; Béla D; Ferenczi Ö; Major T; Polgár C; Takácsi-Nagy Z
    Radiol Oncol; 2018 Nov; 52(4):461-467. PubMed ID: 30422804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high dose volumetric CT on PTV margin reduction in VMAT prostate radiotherapy.
    Cho YB; Alasti H; Kong V; Catton C; Berlin A; Chung P; Bayley A; Jaffray D
    Phys Med Biol; 2019 Mar; 64(6):065017. PubMed ID: 30731450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
    Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.
    Chen AM; Yu Y; Daly ME; Farwell DG; Benedict SH; Purdy JA
    Head Neck; 2014 Dec; 36(12):1766-72. PubMed ID: 24174221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans.
    Zumsteg Z; DeMarco J; Lee SP; Steinberg ML; Lin CS; McBride W; Lin K; Wang PC; Kupelian P; Lee P
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):712-9. PubMed ID: 22099037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.